Comparative Efficacy and Safety of Twice Daily Fluticasone Propionate Powder Versus Placebo in the Treatment of Moderate Asthma
- 30 April 1997
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 78 (4) , 356-362
- https://doi.org/10.1016/s1081-1206(10)63196-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life.American Journal of Respiratory and Critical Care Medicine, 1995
- Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthmaJournal of Allergy and Clinical Immunology, 1994
- Inhaled corticosteroids: benefits and risks.Thorax, 1992
- The human pharmacology of fluticasone propionateRespiratory Medicine, 1990
- A New Approach to the Treatment of AsthmaNew England Journal of Medicine, 1989
- Use and Misuse of Metered-dose Inhalers by Patients with Chronic Lung Disease: A Controlled, Randomized Trial of Two Instruction MethodsAmerican Review of Respiratory Disease, 1989
- Statement on Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (COPD) and AsthmaAmerican Review of Respiratory Disease, 1987
- Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthmaJournal of Allergy and Clinical Immunology, 1987
- AEROSOL BECLOMETHASONE DIPROPIONATE: A DOSE-RESPONSE STUDY IN CHRONIC BRONCHIAL ASTHMAThe Lancet, 1973
- EFFECT OF BECLOMETHASONE DIPROPIONATE DELIVERED BY AEROSOL IN PATIENTS WITH ASTHMAThe Lancet, 1972